Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Richard Brokx
Introduction
Richard Brokx is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, Brokx is recognized for his innovative approaches to treating various diseases.
Latest Patents
Among his latest patents are the inventions related to LILRB3-binding molecules and FCMR-binding molecules. The LILRB3-binding molecules patent provides novel anti-LILRB3 antibodies, along with pharmaceutical compositions that include these antibodies. This invention offers therapeutic methods for treating diseases such as cancer, autoimmune diseases, and allergic inflammation. Additionally, it can modulate osteoclast differentiation, showcasing its potential in various medical applications. The FCMR-binding molecules patent also presents novel anti-FCMR antibodies and their pharmaceutical compositions, aimed at treating similar diseases, including cancer and autoimmune disorders.
Career Highlights
Richard Brokx is affiliated with the University Health Network, where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies that can significantly impact patient care and treatment outcomes.
Collaborations
Some of his notable coworkers include Jacqueline M Mason and Mark R Bray, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Richard Brokx's innovative work in the field of biotechnology, particularly through his patents, highlights his commitment to advancing medical science. His contributions are essential in the ongoing fight against complex diseases, and his collaborations further enhance the impact of his research.